• 25

    January

    43 research talents awarded scholarships to help secure Denmark’s future ... Read more

    24

    January

    Novo Nordisk establishes type 1 diabetes R&D center in Seattle ... Read more

    06

    December

    Data show that the combination insulin degludec/insulin aspart significantly red ... Read more

    05

    December

    Study in type 2 diabetes shows low rates of hypoglycaemia and significant improv ... Read more

  • 20

    February

    Novo Nordisk A/S - Share repurchase programme ... Read more

    13

    February

    Novo Nordisk A/S : Novo Nordisk A/S - Share repurchase programme ... Read more

    09

    February

    Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives a ... Read more

    08

    February

    Novo Nordisk files annual report with the SEC ... Read more

  • 27

    February

    Citi Healthcare Conference

    2

    March

    Credit Suisse 1-1 Healthcare Conference

    12

    March

    Sydbank Investor Arrangement

    14

    March

    Barclays Global Healthcare Conference

Stock quotes

784.50 +0.58

Advanced view

Upcoming events

Novo Nordisk 2012 Annual General Meeting and Shareholders Meeting

The Annual General Meeting will be held on 21 March 2012 at 2:00 pm CET (doors open at 1:00 pm) at Radisson Blu Falconer Hotel & Conference Center, Falkoner Allé 9, 2000 Frederiksberg, Denmark.

Link to the meeting call is available here 

The Shareholders Meeting will be held on 21 March 2012 at 4:30 pm CET (doors open at 4:00 pm) at Radisson Blu Falconer Hotel & Conference Center, Falkoner Allé 9, 2000 Frederiksberg, Denmark.

 

Link to the meeting call is available here

Latest uploads

Conference calls
Full-year 2011 results
IR presentations
Full year 2011 investor presentation London
Interim reports
Full-year 2011 financial statement

Related links

Corporate Governance
Novo Nordisk is committed to the general principles of good corporate governance.

About Novo Nordisk / Corporate governance